Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigm Receives $8.2m R&D Tax Incentive Refund

Jun 7, 2022 at 2:43 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment